Herbert B. Slade
Equibles does not estimate personal net worth.
About Herbert B. Slade
Palisade Bio, Inc. reported in an 8-K filed November 23, 2022 that Herbert B. Slade was appointed Chief Medical Officer, effective November 17, 2022. Palisade Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Palisade Bio, Inc. includes J.D. Finley (CEO, CFO and Board Member), Dane R. Saglio (CFO), Matthew W. Kalnik, Ph.D. (COO) and 7 others.
“On November 17, 2022, the Board of Directors of Palisade Bio, Inc. ("Company") appointed Herbert B. Slade, MD FAAAAI, to serve as the Company's chief medical officer.”
Affiliation history
-
Palisade Bio, Inc. (PALI)
SEC 8-K
Current2022-11-17–present
Company network
Leadership on record at Palisade Bio, Inc.
- J.D. Finley CEO, CFO, Board Member
- Dane R. Saglio CFO
- Matthew W. Kalnik, Ph.D. COO
- Robert McRae COO
- John Rodenrys CTO
- Dane Saglio Chief Accounting Officer
- Binxian Wei Board Member
- Don Williams Board Member
- Donald Williams Board Member
- Emil Chuang Board Member